EUVIMEDEUVIMED entdecken
Übersichtsarbeit

GLP-1 Receptor Agonists in Adolescents: Emerging Endocrine, Reproductive, and Psychosocial Concerns

Muhammad Ali Haider, Haseeba Javed

Journal of Pediatric and Adolescent Gynecology · 2026-12 · 39 (6) · 727-730

DOI: 10.1016/j.jpag.2026.06.017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pediatric and Adolescent Gynecology, 2026-12. Verfasst von Muhammad Ali Haider und 1 weiteren Autor:innen. Beteiligte Einrichtung: HBS Medical and Dental College, Islamabad, Pakistan. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Diabetes Mellitus, Type 2, Pediatric Obesity, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed to adolescents for obesity and type 2 diabetes mellitus (T2DM), with growing interest in extending their use to conditions such as polyendocrine metabolic ovarian syndrome (PMOS, formerly known as polycystic ovary syndrome or PCOS). However, adolescence represents the critical window for peak bone mass acquisition, and the implications of pharmacologic weight loss during this developmental period have received limited attention. Furthermore, this commentary addresses potential concerns related to eating disorder risk and future reproductive outcomes in this population. METHODS This commentary examines the emerging concerns regarding bone health, reproductive safety, eating disorder risk and endocrine development when GLP-1 RAs are used in adolescent populations. RESULTS Adult studies demonstrate improvements in weight loss, insulin resistance, and menstrual regularity with GLP-1 RA therapy. In adolescents with obesity, clinical trials of liraglutide and semaglutide show significant weight reduction without short-term effects on growth or pubertal development. However, adolescence represents a critical period for peak bone mass acquisition, and rapid pharmacologic weight loss may theoretically impair bone mineral accrual. Evidence from adult populations suggests modest reductions in bone mineral density associated with weight loss, while structured exercise may mitigate these effects. GLP-1 RAs are not recommended during pregnancy, and no data exist on reproductive outcomes following adolescent exposure. Additionally, the potent appetite-suppressing effects of these agents raise concerns about potential misuse or exacerbation of eating disorders in adolescents, a population uniquely vulnerable to body image pressures. CONCLUSIONS GLP-1 RAs represent a promising adjunct therapy for adolescents with obesity, T2DM, and PMOS, but long-term skeletal, reproductive, psychological, and endocrine outcomes remain uncertain. Careful patient selection, bone health monitoring, incorporation of resistance exercise, contraceptive counseling, and screening for disordered eating may be essential when these therapies are considered in adolescent populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsDiabetes Mellitus, Type 2Pediatric ObesityHypoglycemic AgentsHumansFemaleAdolescentBone DensitySemaglutidePolycystic Ovary SyndromeWeight LossFeeding and Eating DisordersLiraglutide

Stichwörter der Autor:innen

AdolescenceBone mineral densityEndocrine safetyGLP-1 receptor agonistsPolycystic ovary syndrome

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsSemaglutideHypoglycemic AgentsLiraglutide

Autor:innen und Institutionen

  • HBS Medical and Dental College, Islamabad, Pakistan.
  • Department of Medicine, NYC Health + Hospitals/Elmhurst, Icahn School of Medicine at Mount Sinai, New York. Electronic address: javedh1@nychhc.org.

Zitieren

APA

Haider, M. A., & Javed, H. (2026). GLP-1 Receptor Agonists in Adolescents: Emerging Endocrine, Reproductive, and Psychosocial Concerns. Journal of Pediatric and Adolescent Gynecology, 39(6), 727-730. https://doi.org/10.1016/j.jpag.2026.06.017

Vancouver

Haider MA, Javed H. GLP-1 Receptor Agonists in Adolescents: Emerging Endocrine, Reproductive, and Psychosocial Concerns. Journal of Pediatric and Adolescent Gynecology. 2026;39(6):727-730. doi:10.1016/j.jpag.2026.06.017

BibTeX
@article{Haider2026,
  author = {Haider, Muhammad Ali and Javed, Haseeba},
  title = {GLP-1 Receptor Agonists in Adolescents: Emerging Endocrine, Reproductive, and Psychosocial Concerns},
  journal = {Journal of Pediatric and Adolescent Gynecology},
  year = {2026},
  volume = {39},
  number = {6},
  pages = {727--730},
  doi = {10.1016/j.jpag.2026.06.017}
}
Kostenlos starten →